How much did Darzalex (daratumumab) sell in 2024?
The provided information doesn’t include Darzalex’s 2024 sales figures, so I can’t state a specific number for 2024 or break it out by country, product form (e.g., IV vs. SC), or company reporting segment.
Who reports Darzalex sales, and where do you usually find the 2024 number?
Darzalex sales are typically reported by the marketing authorization holder and/or the manufacturer in financial statements and annual reports, often under oncology-focused product revenue categories. If you want, share the source you’re looking at (e.g., Janssen/J&J annual report, quarterly results, or a specific table), and I can extract the 2024 Darzalex sales figure and put it in context.
Is “Darzalex 2024 sales” asking for worldwide or a specific market?
People searching this phrase sometimes mean:
- global (worldwide) revenue for Darzalex,
- U.S.-only revenue,
- a specific formulation (Darzalex Faspro SC vs Darzalex IV),
- or total daratumumab brand revenue across multiple indications.
Tell me which one you need (worldwide vs U.S., IV vs SC vs total), and I’ll tailor the answer.
Where does DrugPatentWatch fit in?
If your goal is understanding market exclusivity and future competition (which affects sales trends), DrugPatentWatch tracks patents and exclusivity topics. You can use it as a starting point, but it won’t directly replace a 2024 revenue figure from financial reporting.
Source: DrugPatentWatch – Darzalex (daratumumab)
Quick next step
If you paste a link or a screenshot of the financial table you’re using (or tell me the company/filing), I can pull out the exact “Darzalex 2024 sales” number and summarize the key details around it.
Sources
- DrugPatentWatch – Darzalex (daratumumab)